BATTAGLIA, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 9.650
AS - Asia 4.386
EU - Europa 2.058
AF - Africa 719
SA - Sud America 663
OC - Oceania 73
Continente sconosciuto - Info sul continente non disponibili 71
Totale 17.620
Nazione #
US - Stati Uniti d'America 9.238
SG - Singapore 1.451
CN - Cina 697
VN - Vietnam 687
HK - Hong Kong 424
BR - Brasile 384
IT - Italia 270
FI - Finlandia 198
SE - Svezia 176
DE - Germania 175
FR - Francia 170
BD - Bangladesh 165
UA - Ucraina 149
IN - India 137
GB - Regno Unito 118
PL - Polonia 110
RU - Federazione Russa 72
AR - Argentina 60
IQ - Iraq 60
JP - Giappone 53
PK - Pakistan 52
TR - Turchia 50
ZA - Sudafrica 46
AT - Austria 45
PH - Filippine 45
CA - Canada 44
NL - Olanda 44
ID - Indonesia 43
ES - Italia 40
MX - Messico 40
UZ - Uzbekistan 37
CO - Colombia 35
SA - Arabia Saudita 35
KE - Kenya 34
EC - Ecuador 32
BJ - Benin 31
PY - Paraguay 30
RS - Serbia 30
AU - Australia 29
IE - Irlanda 28
NI - Nicaragua 28
VE - Venezuela 27
CZ - Repubblica Ceca 26
GR - Grecia 26
AO - Angola 25
LV - Lettonia 25
MN - Mongolia 25
PA - Panama 25
DZ - Algeria 24
PE - Perù 24
LB - Libano 23
MK - Macedonia 23
MY - Malesia 23
NP - Nepal 23
TN - Tunisia 23
TZ - Tanzania 23
BA - Bosnia-Erzegovina 22
CL - Cile 22
IL - Israele 22
KH - Cambogia 22
KR - Corea 22
AE - Emirati Arabi Uniti 21
BB - Barbados 21
DO - Repubblica Dominicana 21
EG - Egitto 21
GA - Gabon 21
HU - Ungheria 21
SK - Slovacchia (Repubblica Slovacca) 21
BE - Belgio 20
CI - Costa d'Avorio 20
CR - Costa Rica 20
CV - Capo Verde 20
GT - Guatemala 20
JM - Giamaica 20
LU - Lussemburgo 20
MA - Marocco 20
TT - Trinidad e Tobago 20
AZ - Azerbaigian 19
BO - Bolivia 19
ET - Etiopia 19
KZ - Kazakistan 19
LC - Santa Lucia 19
LY - Libia 19
PR - Porto Rico 19
PT - Portogallo 19
SD - Sudan 19
SI - Slovenia 19
SN - Senegal 19
XK - ???statistics.table.value.countryCode.XK??? 19
YE - Yemen 19
BS - Bahamas 18
CW - ???statistics.table.value.countryCode.CW??? 18
GE - Georgia 18
HR - Croazia 18
LA - Repubblica Popolare Democratica del Laos 18
MU - Mauritius 18
MZ - Mozambico 18
TH - Thailandia 18
TW - Taiwan 18
AL - Albania 17
Totale 16.820
Città #
Fairfield 957
Ashburn 956
Singapore 903
San Jose 802
Houston 787
Woodbridge 702
Ann Arbor 511
Jacksonville 501
Chandler 479
Wilmington 381
Hong Kong 379
Seattle 352
Cambridge 316
Santa Clara 247
Ho Chi Minh City 202
Princeton 187
Hanoi 175
Boardman 165
Los Angeles 130
Beijing 128
San Diego 97
Helsinki 90
New York 86
Lauterbourg 85
Roxbury 83
Bytom 81
Des Moines 63
Nanjing 57
Medford 49
Dong Ket 44
Chicago 41
Da Nang 38
Guangzhou 37
Buffalo 35
São Paulo 34
Milan 33
Nairobi 32
Tashkent 32
Cotonou 29
Tokyo 29
Managua 28
Vienna 27
Dallas 26
Haiphong 26
Munich 26
Baghdad 25
Orem 25
Dublin 24
Panama City 24
Nuremberg 23
Ulan Bator 23
Belgrade 21
Libreville 21
London 21
Norwalk 21
Phnom Penh 21
The Dalles 21
Falls Church 20
Nanchang 20
Riga 20
Baku 19
Bridgetown 19
Castries 19
Dakar 19
Luanda 19
Shanghai 19
Atlanta 18
Boston 18
Nassau 18
Padova 18
San José 18
Abidjan 17
Frankfurt am Main 17
Kigali 17
Rome 17
Vientiane 17
Warsaw 17
Bamako 16
Bishkek 16
Cape Town 16
Dar es Salaam 16
Jeddah 16
Maputo 16
Praia 16
Shenyang 16
Stockholm 16
Brooklyn 15
Chennai 15
Harare 15
Johannesburg 15
Kampala 15
Montevideo 15
Rio de Janeiro 15
San Francisco 15
Skopje 15
Addis Ababa 14
Hebei 14
Podgorica 14
Bangkok 13
Council Bluffs 13
Totale 11.451
Nome #
Detection of genetic alterations in cfDNA as a possible strategy to monitor the neoplastic progression of Barrett's esophagus 315
Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study. 313
In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma 294
Insulin promotes HER2 signaling activation during Barrett's Esophagus carcinogenesis 282
A germline predictive signature of response to platinum chemotherapy in esophageal cancer 281
Comparison of preoperative and surgical measurements of Zenker's diverticulum. 278
MicroRNA expression profiling in human Barrett's carcinogenesis. 276
Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett’s esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population 265
PALLIATIVE TREATMENT OF HEPATOCELLULAR CARCINOMA WITH TRANSCATHETER ARTERIAL EMBOLIZATION. 262
Anastomotic stenoses occurring after circular stapling in esophageal cancer surgery 254
Aurora kinase A in Barrett's carcinogenesis. 253
Liquid biopsy as a novel tool to monitor the carcinogenesis of Barrett's esophagus 252
Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. 250
Azithromycin for the cure of Helicobacter pylori infection 249
A new endoscopic technique for suspension of esophageal prosthesis for refractory caustic esophageal strictures 248
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. 240
CYTOPROTECTIVE EFFECTS OF COLLOIDAL BISMUTH SUBCITRATE IN PATIENTS WITH ULCER DISEASE 234
Programmed cell death 4 protein in esophageal cancer 234
Barrett’s Esophagus and Adenocarcinoma Risk The Experience of the North-Eastern Italian Registry (EBRA) 232
The Role of Helicobacter pylori in the Spectrum of Barrett's Carcinogenesis 229
Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma. 228
Mediastinal carcinosis involving the esophagus in breast cancer: the"breast-esophagus" syndrome: report on 25 cases and guidelines for diagnosis andtreatment. 226
Barrett's epithelium after antireflux surgery 221
The Veneto Region's Barrett's Oesophagus Registry: Aims, methods, preliminary results. 220
A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia 210
Detection of fluorescent organic nanoparticles by confocal laser endomicroscopy in a rat model of Barrett's esophageal adenocarcinoma 210
The role of flexible endotherapy for the treatment of recurrent Zenker’s diverticula after surgery and endoscopic stapling 204
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks? 199
Barrett's epithelium after antireflux surgery 199
Endoscopic treatment of pseudosarcomatous squamous carcinoma of the esophagus: case report and personal experience 192
Erosion of an esophageal endoprosthesis into the trachea 190
Computer Aided Diagnosis of Barrett's Esophagus Using Confocal Laser Endomicroscopy: Preliminary Data 190
TREATMENT OF LIVER ABSCESS:PERCUTANEOUS CATHETER DRAINAGE VERSUS SURGICAL DRAINAGE. 189
High-frequency miniprobes and 3-dimensional EUS for preoperative evaluation of the etiology of congenital esophageal stenosis in children (with video). 187
Caustic ingestion and oesophageal cancer: intra- and peri-tumoral fibrosis is associated with a better prognosis 187
Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia 185
Early HER2 dysregulation in gastric and oesophageal carcinogenesis. 181
Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia 181
Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study. 180
Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis (vol 63, pg 692, 2010) 180
H-pylori eradication in gastric ulcer disease: One year prospective multicenter study 177
The appearance of gord in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study. 177
Prediction of lymph node status in superficial esophageal carcinoma. 176
Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia 176
Etiology, diagnosis and treatment of failures after laparoscopic Heller Myotomy for achalasia 174
Helicobacter pylori in promotion of gastric carcinogenesis 174
Diagnosis and Endoscopic Management of Barrett's Esophagus: an Italian Experts’ Opinion based document 172
COMPARISON OF 3 DIFFERENT THERAPEUTIC REGIMENS FOR ERADICATING HELICOBACTER-PYLORI 170
Hybrid patch-based and image-wide classification of confocal laser endomicroscopy images in Barrett’s esophagus surveillance 170
Role of Confocal Laser Endomicroscopy in Detection of Residual Barrett's Esophagus after Radiofrequency Ablation 168
Management of esophageal cancer in patients aged over 80 years. 168
Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy. 164
CEFIXIME FOR THE ERADICATION OF HELICOBACTER-PYLORI 163
EARLY DROP IN ANTIHELICOBACTER-PYLORI IGG TITER AFTER ERADICATION THERAPY WITH CLARITHROMYCIN 163
An unusual complication of eosinophilic esophagitis in an adolescent: intramural esophageal dissection. 162
Four Hundred Laparoscopic Myotomies for Esophageal Achalasia A Single Centre Experience 161
Gastrointestinal stromal tumors: report of an audit and review of the literature 156
PPIS plus H-2-antagonists for non-responders GERD patients: A rescue therapy? (A three months pilot study). 155
Programmed cell desth 4 (PDCD4) expression during multistep Barett's carcinogenesis. 152
The Experience on PDT by the Multidisciplinary Group in Padova 151
Endoscopic ultrasound: accuracy in staging superficial carcinomas of the esophagus 149
Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 year study. 148
Effects of nadolol treatment on renal and hepatic haemodynamics and function in cirrhotic patients with portal hypertension. 148
Retreatment after failure of Helicobacter pylori eradication: Quadruple vs ranitidine bismuth citrate 2 weeks therapy. 147
Helicobacter pylori eradication in gastric ulcer disease: One year prospective multicenter study 147
Single-band mucosectomy for granular cell tumor of the esophagus: safe and easy technique 147
SERUM PEPSINOGEN-A AND PEPSINOGEN-C LEVELS - A FOLLOW-UP-STUDY ON 476 PATIENTS AFTER HELICOBACTER-PYLORI ERADICATION 144
MicroRNA Expression Profiling of Human Esophageal Metaplastic Changes 143
Polyflex stents for malignant oesophageal and oesophagogastric stricture: aprospective, multicentric study. 142
The prevalence of esophagitis in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: One year follow-up. 141
AZITHROMYCIN - A NEW USEFUL THERAPEUTIC STRATEGY FOR THE ERADICATION OF HELICOBACTER-PYLORI INFECTION - MODIFICATION OF SERUM GASTRIN, PEPSINOGENS AND ANTI-HP ANTIBODIES (IGG) 141
TRATTAMENTO PALLIATIVO DELL'EPATOCARCINOMA NON RESECABILE CON CHEMIOEMBOLIZZAZIONE. 141
Role of acid and bile reflux in development of specialised intestinal metaplasia in distal oesophagus 139
Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). 138
Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 years study 136
Computer Aided Diagnosis Of Barrett’s Esophagus And Associated Neoplasia Using Confocal Laser Endomicroscopy: Preliminary Data 136
Barrett's esophagus: management of high-grade dysplasia and cancer 134
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-easth Italy: A prospective descriptive survey. The Italian Ulcer Study Group (GISU) 133
Derivazione spleno-renale distale selettiva vs devascolarizzazione esofago-gastrica con transezione esofagea. Studio prospettico controllato. 131
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey 130
One year prospective multicenter study after eradication in Helicobacter pylori positive gastric ulcer disease. 126
Which stent stenosis of the esophagus which [Quale stent in quale stenosi dell'esofago]. 124
Computer Aided Diagnosis Of Barrett’s Esophagus And Associated Neoplasia Using Confocal Laser Endomicroscopy 124
Is non ulcer dyspepsia an indication for Helicobacter pylori eradication? A one year prospective study. 124
Long‐Term pH and Manometric Evaluation of the Distal Esophagus After Endoscopic Sclerotherapy of Esophageal Varices 124
The "very bed" H pylori: Experience on 69 consecutive patients after the failure of the second eradication treatment. 121
EFFETTI EMODINAMICI DELLA TRYGLYCYL-LYSINE-VASOPRESSIN: STUDIO ANGIOGRAFICO. 119
Quadruple therapy versus ranitidine bismuth citrate after failure of standard triple therapy 118
TERAPIA ENDOSCOPICA DELLE VARICI GASTRICHE CON CIANOACRILATO 118
Enteryx(tm) implantation in the treatment of GERD: Results of a national, multicentre study in Italy confirm prior efficacy results 118
Visceral fistula as a complication of endoscopic treatment of esophageal and gastric varices using isobutyl-2-cyanoacrylate: report of two cases 118
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 116
IMPLICAZIONI RADIOLOGICHE DELLA SCLEROSI ENDOSCOPICA CON CIANOACRILATO DELLE VARICI GASTRICHE. 114
Helicobacter pylori eradication in functional dyspepsia: A prospective randomized six months study. 110
LA LEGATURA DELLE VARICI ESOFAGEE: UNA NUOVA TECNICA ENDOSCOPICA 108
LA DIAGNOSI E LA TERAPIA ENDOSCOPICA DELLE EMORRAGIE DIGESTIVE ALTE 105
Ulcera duodenale e iperpepsinogenemi: decorso clinico e risposta gastrinemica al pasto 104
Hemodynamic changes on systemic, hepatic and splenic circulations following triglycyl-lysin-va¬sopressin administration in alcoholic cirrhosis. 102
The role of acid and bile reflux in the development of specialized metaplasia in the distal esophagus 98
Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). 85
Totale 17.620
Categoria #
all - tutte 49.923
article - articoli 48.425
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.232 0 152 162 90 63 71 47 153 53 24 142 275
2022/2023997 229 89 28 127 178 139 0 52 115 5 28 7
2023/2024434 20 81 37 35 35 61 20 24 16 6 51 48
2024/20251.770 13 92 83 59 249 46 66 134 132 84 311 501
2025/20267.760 219 561 1.021 1.199 654 353 1.077 824 830 476 326 220
2026/2027502 434 68 0 0 0 0 0 0 0 0 0 0
Totale 17.620